Diagnostic Tumor Markers in Head and Neck Squamous Cell Carcinoma (HNSCC) in the Clinical Setting
来源期刊:Frontiers in OncologyDOI:10.3389/fonc.2019.00827
Radiotherapy Both Promotes and Inhibits Myeloid-Derived Suppressor Cell Function: Novel Strategies for Preventing the Tumor-Protective Effects of Radiotherapy
来源期刊:Frontiers in OncologyDOI:10.3389/fonc.2019.00215
Induction of Pyroptosis and Its Implications in Cancer Management
来源期刊:Frontiers in OncologyDOI:10.3389/fonc.2019.00971
Role of Microenvironment on the Fate of Disseminating Cancer Stem Cells
来源期刊:Frontiers in OncologyDOI:10.3389/fonc.2019.00082
Expanding the Arsenal of FGFR Inhibitors: A Novel Chloroacetamide Derivative as a New Irreversible Agent With Anti-proliferative Activity Against FGFR1-Amplified Lung Cancer Cell Lines
来源期刊:Frontiers in OncologyDOI:10.3389/fonc.2019.00179
Development of a 21-miRNA Signature Associated With the Prognosis of Patients With Bladder Cancer
来源期刊:Frontiers in OncologyDOI:10.3389/fonc.2019.00729
Proteasomes and Several Aspects of Their Heterogeneity Relevant to Cancer
来源期刊:Frontiers in OncologyDOI:10.3389/fonc.2019.00761
Metadherin: A Therapeutic Target in Multiple Cancers
来源期刊:Frontiers in OncologyDOI:10.3389/fonc.2019.00349
Development and Validation of a Prognostic Signature for Malignant Pleural Mesothelioma
来源期刊:Frontiers in OncologyDOI:10.3389/fonc.2019.00078
Characterization of Pancreatic Cancer Tissue Using Multiphoton Excitation Fluorescence and Polarization-Sensitive Harmonic Generation Microscopy
来源期刊:Frontiers in OncologyDOI:10.3389/fonc.2019.00272
Ovine Pulmonary Adenocarcinoma: A Unique Model to Improve Lung Cancer Research
来源期刊:Frontiers in OncologyDOI:10.3389/fonc.2019.00335
Spine SBRT With Halcyon™: Plan Quality, Modulation Complexity, Delivery Accuracy, and Speed
来源期刊:Frontiers in OncologyDOI:10.3389/fonc.2019.00319
Capsaicin Induces Apoptosis in KSHV-Positive Primary Effusion Lymphoma by Suppressing ERK and p38 MAPK Signaling and IL-6 Expression
来源期刊:Frontiers in OncologyDOI:10.3389/fonc.2019.00083
Is Proton Therapy a “Pro” for Breast Cancer? A Comparison of Proton vs. Non-proton Radiotherapy Using the National Cancer Database
来源期刊:Frontiers in OncologyDOI:10.3389/fonc.2018.00678
Regulatory Mechanisms and Clinical Applications of the Long Non-coding RNA PVT1 in Cancer Treatment
来源期刊:Frontiers in OncologyDOI:10.3389/fonc.2019.00787
Confocal-Assisted Multispectral Fluorescent Microscopy for Brain Tumor Surgery
来源期刊:Frontiers in OncologyDOI:10.3389/fonc.2019.00583
Targeting IL-6 Is a Potential Treatment for Primary Cystic Craniopharyngioma
来源期刊:Frontiers in OncologyDOI:10.3389/fonc.2019.00791
MicroRNA and mRNA Interaction Network Regulates the Malignant Transformation of Human Bronchial Epithelial Cells Induced by Cigarette Smoke
来源期刊:Frontiers in OncologyDOI:10.3389/fonc.2019.01029
Aspirin Inhibits Natural Killer/T-Cell Lymphoma by Modulation of VEGF Expression and Mitochondrial Function
来源期刊:Frontiers in OncologyDOI:10.3389/fonc.2018.00679
Specificity of Biogenic Selenium Nanoparticles for Prostate Cancer Therapy With Reduced Risk of Toxicity: An in vitro and in vivo Study
来源期刊:Frontiers in OncologyDOI:10.3389/fonc.2019.01541
Precision Medicine in Lymphoma by Innovative Instrumental Platforms
来源期刊:Frontiers in OncologyDOI:10.3389/fonc.2019.01417
Identification of SPP1 as an Extracellular Matrix Signature for Metastatic Castration-Resistant Prostate Cancer
来源期刊:Frontiers in OncologyDOI:10.3389/fonc.2019.00924
O6-Methylguanine-DNA Methyltransferase (MGMT): Challenges and New Opportunities in Glioma Chemotherapy
来源期刊:Frontiers in OncologyDOI:10.3389/fonc.2019.01547
The Interplay Between the DNA Damage Response, RNA Processing and Extracellular Vesicles
来源期刊:Frontiers in OncologyDOI:10.3389/fonc.2019.01538
“Après Mois, Le Déluge”: Preparing for the Coming Data Flood in the MRI-Guided Radiotherapy Era
来源期刊:Frontiers in OncologyDOI:10.3389/fonc.2019.00983
MicroRNA (miR)-597-5p Inhibits Colon Cancer Cell Migration and Invasion by Targeting FOS-Like Antigen 2 (FOSL2)
来源期刊:Frontiers in OncologyDOI:10.3389/fonc.2019.00495
Nanoformulation of Talazoparib Increases Maximum Tolerated Doses in Combination With Temozolomide for Treatment of Ewing Sarcoma
来源期刊:Frontiers in OncologyDOI:10.3389/fonc.2019.01416
Dissecting the Multiplicity of Immune Effects of Immunosuppressive Drugs to Better Predict the Risk of de novo Malignancies in Solid Organ Transplant Patients
来源期刊:Frontiers in OncologyDOI:10.3389/fonc.2019.00160
Role of Regenerating Islet-Derived Protein 3A in Gastrointestinal Cancer
来源期刊:Frontiers in OncologyDOI:10.3389/fonc.2019.01449
Mutation Spectrum of Cancer-Associated Genes in Patients With Early Onset of Colorectal Cancer
来源期刊:Frontiers in OncologyDOI:10.3389/fonc.2019.00673
The Impact of Timing of Concurrent Chemoradiation in Patients With High-Grade Glioma in the Era of the Stupp Protocol
来源期刊:Frontiers in OncologyDOI:10.3389/fonc.2019.00186
Clinical Characteristics of Gliosarcoma and Outcomes From Standardized Treatment Relative to Conventional Glioblastoma
来源期刊:Frontiers in OncologyDOI:10.3389/fonc.2019.01425
Herbal Interaction With Chemotherapeutic Drugs—A Focus on Clinically Significant Findings
来源期刊:Frontiers in OncologyDOI:10.3389/fonc.2019.01356
Role of Sirtuins in Tumor Angiogenesis
来源期刊:Frontiers in OncologyDOI:10.3389/fonc.2019.01516
Modeling Gene-Environment Interaction for the Risk of Non-hodgkin Lymphoma
来源期刊:Frontiers in OncologyDOI:10.3389/fonc.2018.00657
Spray Fluorescent Probes for Fluorescence-Guided Neurosurgery
来源期刊:Frontiers in OncologyDOI:10.3389/fonc.2019.00727
Prediction of Metabolic Syndrome for the Survival of Patients With Digestive Tract Cancer: A Meta-Analysis
来源期刊:Frontiers in OncologyDOI:10.3389/fonc.2019.00281
Persistent Basophilia May Suggest an “Accelerated Phase” in the Evolution of CALR-Positive Primary Myelofibrosis Toward Acute Myeloid Leukemia
来源期刊:Frontiers in OncologyDOI:10.3389/fonc.2019.00872
The Association of GSTT1, GSTM1, and TNF-α Polymorphisms With the Risk and Outcome in Multiple Myeloma
来源期刊:Frontiers in OncologyDOI:10.3389/fonc.2019.01056
Identification of RE1-Silencing Transcription Factor as a Promoter of Metastasis in Pancreatic Cancer
来源期刊:Frontiers in OncologyDOI:10.3389/fonc.2019.00291
BAG3 Suppresses Loading of Ago2 to IL6 mRNA in Pancreatic Ductal Adenocarcinoma
来源期刊:Frontiers in OncologyDOI:10.3389/fonc.2019.00225
SEMA3C Promotes Cervical Cancer Growth and Is Associated With Poor Prognosis
来源期刊:Frontiers in OncologyDOI:10.3389/fonc.2019.01035
Reliability and Agreement of the 10-Repetition Maximum Test in Breast Cancer Survivors
来源期刊:Frontiers in OncologyDOI:10.3389/fonc.2019.00918
Prognostic and Risk Stratification Value of Lesion MACC1 Expression in Colorectal Cancer Patients
来源期刊:Frontiers in OncologyDOI:10.3389/fonc.2019.00028
Bevacizumab Combined With Oxaliplatin/Capecitabine in Patient With Refractory and Recurrent Mucinous Adenocarcinoma of the Appendix: A Case Report
来源期刊:Frontiers in OncologyDOI:10.3389/fonc.2019.00055
Integrative Analysis Reveals Across-Cancer Expression Patterns and Clinical Relevance of Ribonucleotide Reductase in Human Cancers
来源期刊:Frontiers in OncologyDOI:10.3389/fonc.2019.00956
Early Mortality of Prostatectomy vs. Radiotherapy as a Primary Treatment for Prostate Cancer: A Population-Based Study From the United States and East Germany
来源期刊:Frontiers in OncologyDOI:10.3389/fonc.2019.01451
Taiwanin E Induces Cell Cycle Arrest and Apoptosis in Arecoline/4-NQO-Induced Oral Cancer Cells Through Modulation of the ERK Signaling Pathway
来源期刊:Frontiers in OncologyDOI:10.3389/fonc.2019.01309
Pigment Epithelium-Derived Factor Promotes the Growth and Migration of Human Esophageal Squamous Cell Carcinoma
来源期刊:Frontiers in OncologyDOI:10.3389/fonc.2019.01520
On the Feasibility of Stereotactic Radiosurgery With 5.0 and 10.0 mm MLC Leaves as a Function of Target Size and Shape
来源期刊:Frontiers in OncologyDOI:10.3389/fonc.2019.00741